CD4 and hepatocellular carcinoma: The high expression of IL-17 and IL-17RE is a promising predictor of poor prognosis in HCC. The precursor capacity of the CD4+ T cells that produce IL-17 may be involved in cross-talk of different types of inflammatory/immune cells than in HCC.